FBIO vs. SNY
Compare and contrast key facts about Fortress Biotech, Inc. (FBIO) and Sanofi (SNY).
Performance
FBIO vs. SNY - Performance Comparison
Loading graphics...
FBIO vs. SNY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBIO Fortress Biotech, Inc. | -32.51% | 80.74% | -32.72% | -69.36% | -73.80% | -21.14% | 23.35% | 198.84% | -78.45% | 47.78% |
SNY Sanofi | -1.51% | 4.93% | 1.09% | 6.55% | 0.57% | 7.00% | 0.39% | 20.47% | 6.06% | 9.96% |
Fundamentals
FBIO:
$689.18M
SNY:
$116.50B
FBIO:
-$0.28
SNY:
$3.18
FBIO:
4.45
SNY:
2.51
FBIO:
13.82
SNY:
1.63
FBIO:
$63.25M
SNY:
$46.72B
FBIO:
$31.70M
SNY:
$33.79B
FBIO:
-$21.61M
SNY:
$12.68B
Returns By Period
In the year-to-date period, FBIO achieves a -32.51% return, which is significantly lower than SNY's -1.51% return. Over the past 10 years, FBIO has underperformed SNY with an annualized return of -25.58%, while SNY has yielded a comparatively higher 5.86% annualized return.
FBIO
- 1D
- -11.47%
- 1M
- -25.15%
- YTD
- -32.51%
- 6M
- -3.52%
- 1Y
- 60.39%
- 3Y*
- -41.44%
- 5Y*
- -46.76%
- 10Y*
- -25.58%
SNY
- 1D
- -0.93%
- 1M
- 0.15%
- YTD
- -1.51%
- 6M
- -4.08%
- 1Y
- -8.27%
- 3Y*
- -0.31%
- 5Y*
- 3.35%
- 10Y*
- 5.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBIO vs. SNY — Risk / Return Rank
FBIO
SNY
FBIO vs. SNY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fortress Biotech, Inc. (FBIO) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBIO | SNY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.77 | -0.30 | +1.07 |
Sortino ratioReturn per unit of downside risk | 1.52 | -0.23 | +1.75 |
Omega ratioGain probability vs. loss probability | 1.21 | 0.97 | +0.24 |
Calmar ratioReturn relative to maximum drawdown | 1.34 | -0.57 | +1.90 |
Martin ratioReturn relative to average drawdown | 2.87 | -1.12 | +3.99 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBIO | SNY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.77 | -0.30 | +1.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.54 | 0.14 | -0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.30 | 0.25 | -0.55 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.30 | 0.21 | -0.52 |
Correlation
The correlation between FBIO and SNY is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
FBIO vs. SNY - Dividend Comparison
FBIO has not paid dividends to shareholders, while SNY's dividend yield for the trailing twelve months is around 4.63%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIO Fortress Biotech, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SNY Sanofi | 4.63% | 4.56% | 4.22% | 3.83% | 4.32% | 3.80% | 3.61% | 3.47% | 4.29% | 3.82% | 4.11% | 3.77% |
Drawdowns
FBIO vs. SNY - Drawdown Comparison
The maximum FBIO drawdown since its inception was -99.27%, which is greater than SNY's maximum drawdown of -46.46%. Use the drawdown chart below to compare losses from any high point for FBIO and SNY.
Loading graphics...
Drawdown Indicators
| FBIO | SNY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.27% | -46.46% | -52.81% |
Max Drawdown (1Y)Largest decline over 1 year | -43.61% | -17.87% | -25.74% |
Max Drawdown (5Y)Largest decline over 5 years | -98.41% | -33.52% | -64.89% |
Max Drawdown (10Y)Largest decline over 10 years | -98.41% | -33.52% | -64.89% |
Current DrawdownCurrent decline from peak | -98.63% | -16.11% | -82.52% |
Average DrawdownAverage peak-to-trough decline | -77.20% | -12.15% | -65.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.32% | 9.06% | +11.26% |
Volatility
FBIO vs. SNY - Volatility Comparison
Fortress Biotech, Inc. (FBIO) has a higher volatility of 18.05% compared to Sanofi (SNY) at 6.79%. This indicates that FBIO's price experiences larger fluctuations and is considered to be riskier than SNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBIO | SNY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.05% | 6.79% | +11.26% |
Volatility (6M)Calculated over the trailing 6-month period | 61.78% | 16.85% | +44.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.79% | 27.50% | +51.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.39% | 24.65% | +62.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.27% | 23.51% | +61.76% |
Financials
FBIO vs. SNY - Financials Comparison
This section allows you to compare key financial metrics between Fortress Biotech, Inc. and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities